← Open Payments lookup

ASHLIN CHARBONEAU: Open Payments

NPI 1114571536 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$976 in 32 payments from 13 companies in 2025. Trend: 2023 $2,414 · 2024 $2,891 · 2025 $976

Food & beverage: $976
CompanyPaymentsAmount
ABBVIE INC.5$236
Novartis Pharmaceuticals Corporation5$153
GlaxoSmithKline, LLC.4$100
Incyte Corporation3$79
AstraZeneca Pharmaceuticals LP2$66
Astellas Pharma US Inc2$63
Syndax Pharmaceuticals, Inc.2$62
Adaptive Biotechnologies Corporation3$58
Lilly USA, LLC2$53
TAIHO ONCOLOGY, INC.1$35

Products named: SCEMBLIX, IMBRUVICA, OJJAARA, JAKAFI, VENCLEXTA, CALQUENCE, clonoSEQ, JAYPIRCA.

Industry payments across TX — which companies pay providers there.